Evidence map›Paper›PMID 31274109›Full record

ArticleeLife2019

Alexandra M Stafford, Cheryl Reed, Harue Baba, Nicole Ar Walter, John Rk Mootz, Robert W Williams, Kim A Neve, Lev M Fedorov, Aaron J Janowsky, Tamara J Phillips

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Robust aversive effects of trace amine-associated receptor 1 activation in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  8. Article
  9. Trace amine-associated receptor 1 and drug abuse.Advances in pharmacology (San Diego, Calif.) · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Confirmation of a CausalFrontiers in psychiatry · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alexandra M Stafford *Department of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.ORCID 0000-0003-4045-1888
Cheryl Reed *Department of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.ORCID 0000-0002-8798-2347
Harue BabaDepartment of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.
Nicole Ar WalterDivision of Neuroscience, Oregon National Primate Research Center, Portland, United States.
John Rk MootzDepartment of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.
Robert W WilliamsDepartment of Genetics, Genomics and Informatics, University of Tennessee Health Sciences Center, Memphis, United States.
Kim A NeveDepartment of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.ORCID 0000-0003-0109-7345
Lev M FedorovTransgenic Mouse Models Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, United States.
Aaron J JanowskyDepartment of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.
Tamara J PhillipsDepartment of Behavioral Neuroscience and Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, United States.ORCID 0000-0002-7350-6323
Oregon Health & Science University · USOregon National Primate Research Center · USUniversity of Tennessee Health Science Center · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
Traditional Service Core [Translational Service Core (TSC)]P50DA018165 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BELKNAP, JOHN K · 2006 to 2016
$13.0M
BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
TIM Project NIDA P30 CenterP30DA044223 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WILLIAMS, ROBERT W. · 2017 to 2021
$3.9M
Genetic Risk for Methamphetamine AbuseU01DA041579 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PHILLIPS, TAMARA J. · 2016 to 2020
$2.1M
Genetic Factors Underlying Risk for Methamphetamine Intake and Associated TraitsR01DA046081 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI PHILLIPS, TAMARA J. · 2018 to 2022
$1.7M
Opioid Sensitive GABA inputs to the Ventral MidbrainR01DA034388 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2012 to 2016
$967k
Genetic basis of methamphetamine intakeI01BX002106 · VA · PORTLAND VA MEDICAL CENTER · PI PHILLIPS, TAMARA J. · 2014 to 2022
–
Dopamine D2 Receptor Splice Variants and Autoreceptor FunctionI01BX003279 · VA · PORTLAND VA MEDICAL CENTER · PI NEVE, KIM ARTHUR · 2017 to 2020
–
BLRD VA I01 BX002106BLRD VA I01 BX002758BLRD VA I01 BX003279BLRD VA IK6 BX006342NIDA NIH HHS P30 DA044223NIDA NIH HHS P50 DA018165NIDA NIH HHS R01 DA034388NIDA NIH HHS R01 DA046081NIDA NIH HHS T32 DA007027NIDA NIH HHS T32 DA007262NIDA NIH HHS U01 DA041579VA I01BX002106VA I01BX002758VA I01BX003279
6 · The paper itself

Abstract

We identified a locus on mouse chromosome 10 that accounts for 60% of the genetic variance in methamphetamine intake in mice selectively bred for high versus low methamphetamine consumption. We nominated the trace amine-associated receptor 1 gene,

Indexed as

Genetic VariationAnimalsBase SequenceBody TemperatureChromosomes, MammalianFemaleGenotypeHypothermiaMaleMethamphetamineMiceQuantitative Trait LociReceptors, G-Protein-CoupledReceptors, Opioid, muTrace Amine-Associated ReceptorsMethamphetamineOprm protein, mouseReceptors, G-Protein-CoupledReceptors, Opioid, muTrace Amine-Associated ReceptorsaddictionCRISPR-Cas9geneticsgenomicshypothermiamousemu-opioid receptorneuroscienceself administrationtrace amine-associated receptor 1

Identifiers

PMID31274109
PMCPMC6682400
OpenAlexW2953936710

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.